Veeral Haresh Ajmera MD
Hepatology & Liver Transplantation
Associate Professor of Medicine-University of California, San Diego Medical Director of Liver Transplantation
Join to View Full Profile
9350 Campus Point DrLa Jolla, CA 92037
Phone+1 619-543-1884
Fax+1 619-543-3183
Dr. Ajmera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Gastroenterology, 2013 - 2016
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2010 - 2013
University of Texas Southwestern Medical SchoolClass of 2010
Certifications & Licensure
CA State Medical License 2013 - 2027
MA State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2021 Aug 12
Roles: Contact
Publications & Presentations
PubMed
- Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.Luis Antonio Diaz, Maja Thiele, Alexandre Louvet, Brian P Lee, Veeral Ajmera
Nature Reviews. Gastroenterology & Hepatology. 2025-12-01 - 3 citationsA prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction.P Jonathan Li, Parissa Tabrizian, Darine Daher, Felipe Gaviria, Veeral Ajmera
Hepatology. 2025-12-01 - Editorial: Comparable Hepatic Fibrosis Risk Demands Equal Vigilance in Lean and Non-Lean Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease-Authors...Kaleb Tesfai, Luis Antonio Díaz, Veeral Ajmera
Alimentary Pharmacology & Therapeutics. 2025-11-11
Press Mentions
Clinical Trials Revolutionize Patient’s Liver DiseaseAugust 25th, 2025- Clinical Trials Revolutionize Patient’s Liver DiseaseAugust 25th, 2025
- Why Is It so Hard to Treat MASH?April 3rd, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
